The matchup looks lopsided: America's giant drug companies vs. a midsize college over billions of dollars in royalties from a new class of "super aspirin." At the heart of the clash between the University of Rochester and the pharmaceutical behemoths is one question: Should schools get a share of the riches if they make a fundamental discovery and secure a patent but don't set down a clear path to developing a commercial product?
March 26, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Job Summary:Highly successful plaintiff s personal injury firm seeks ASSOCIATE ATTORNEY with 7+ years experience in Labor Law 240 and 241(6)...
Boutique matrimonial family law firm in NYC with high profile practice representing high net worth individuals seeks associate.Qualification...
Columbia Law School invites applicants for a position as full-time Senior Research Scholar, with a focus on those who have research interest...